Issue 1/2015
Content (11 Articles)
Educational Series – Blue Series
Translation in solid cancer: are size‐based response criteria an anachronism?
M. Fernandes, D. Rosel, J. Brábek
Educational Series – Red Series
Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology
J. de Castro, M. Cobo, D. Isla, J. Puente, N. Reguart, B. Cabeza, A. Gayete, M. Sánchez, M. I. Torres, J. Ferreirós
Research Article
Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain
G. Villa, L. J. Hernández-Pastor, M. Guix, J. Lavernia, M. Cuesta
Research Article
EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
Z. Q. Xu, L. Zhang, B. S. Gao, Y. G. Wan, X. H. Zhang, B. Chen, Y. T. Wang, N. Sun, Y. W. Fu
Research Article
Interleukin-17 is a favorable prognostic marker for colorectal cancer
Y. Lin, J. Xu, H. Su, W. Zhong, Y. Yuan, Z. Yu, Y. Fang, H. Zhou, C. Li, K. Huang
Research Article
Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy
L.-P. Ge, J. Li, Q.-L. Bao, P. Chen, Q. Jiang, L.-R. Zhu
Research Article
Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53
Z.-G. Shi, S.-Q. Li, Z.-J. Li, X.-J. Zhu, P. Xu, G. Liu
Research Article
A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products
A. Estévez-Braun, A. G. Ravelo, E. Pérez-Sacau, J. C. Lacal
Correspondence
Indirect comparisons in cost-effectiveness analysis: are we being naïve?
J. Martin-Broto
Acknowledgement to Referees